RT @tripoll: Transthyretin Amyloid Cardiomyopathy: JACC State-of-the-Art Review. - PubMed - NCBI @secardiologia @CardiopatiasS https:/…
RT @tripoll: Transthyretin Amyloid Cardiomyopathy: JACC State-of-the-Art Review. - PubMed - NCBI @secardiologia @CardiopatiasS https:/…
RT @tripoll: Transthyretin Amyloid Cardiomyopathy: JACC State-of-the-Art Review. - PubMed - NCBI @secardiologia @CardiopatiasS https:/…
Transthyretin Amyloid Cardiomyopathy: JACC State-of-the-Art Review. - PubMed - NCBI @secardiologia @CardiopatiasS https://t.co/5mWi9PPZ7K
Transthyretin Amyloid Cardiomyopathy: JACC State-of-the-Art Review. https://t.co/GbzD097ThZ
RT @JACCJournals: #JACC State-of-the-Art Review: This week's issue explores the diagnosis and new treatments for amyloid cardiomyopathy. ht…
RT @JACCJournals: #JACC State-of-the-Art Review: This week's issue explores the diagnosis and new treatments for amyloid cardiomyopathy. ht…
RT @JACCJournals: #JACC State-of-the-Art Review: This week's issue explores the diagnosis and new treatments for amyloid cardiomyopathy. ht…
RT @JACCJournals: #JACC State-of-the-Art Review: This week's issue explores the diagnosis and new treatments for amyloid cardiomyopathy. ht…
Just in the #scintigraph of time: I presented a morning report on AL #cardiac #amyloidosis today AM! Here’s @JACCJournals’ review of the treatments for the #TTR subtype. #amyloid #cardiomyopathy #myeloma #hemeonc
RT @JACCJournals: #JACC State-of-the-Art Review: This week's issue explores the diagnosis and new treatments for amyloid cardiomyopathy. ht…
Fantastic review of cardiac amyloidosis diagnosis and treatment - including the three NEW therapies approved by the FDA since October 2018. #amyloidosis #MedEd
RT @JACCJournals: #JACC State-of-the-Art Review: This week's issue explores the diagnosis and new treatments for amyloid cardiomyopathy. ht…
RT @JACCJournals: #JACC State-of-the-Art Review: This week's issue explores the diagnosis and new treatments for amyloid cardiomyopathy. ht…
RT @JACCJournals: #JACC State-of-the-Art Review: This week's issue explores the diagnosis and new treatments for amyloid cardiomyopathy. ht…
RT @JACCJournals: #JACC State-of-the-Art Review: This week's issue explores the diagnosis and new treatments for amyloid cardiomyopathy. ht…
RT @JTLLERGO: Transthyretin Amyloid Cardiomyopathy: JACC State-of-the-Art Review @JACCJournals @secardiologia @SACardiologia https://t.co/v…
RT @JACCJournals: #JACC State-of-the-Art Review: This week's issue explores the diagnosis and new treatments for amyloid cardiomyopathy. ht…
RT @JACCJournals: #JACC State-of-the-Art Review: This week's issue explores the diagnosis and new treatments for amyloid cardiomyopathy. ht…
RT @JACCJournals: #JACC State-of-the-Art Review: This week's issue explores the diagnosis and new treatments for amyloid cardiomyopathy. ht…
RT @JACCJournals: #JACC State-of-the-Art Review: This week's issue explores the diagnosis and new treatments for amyloid cardiomyopathy. ht…
RT @JACCJournals: #JACC State-of-the-Art Review: This week's issue explores the diagnosis and new treatments for amyloid cardiomyopathy. ht…
RT @JACCJournals: #JACC State-of-the-Art Review: This week's issue explores the diagnosis and new treatments for amyloid cardiomyopathy. ht…
RT @JACCJournals: #JACC State-of-the-Art Review: This week's issue explores the diagnosis and new treatments for amyloid cardiomyopathy. ht…
RT @JACCJournals: #JACC State-of-the-Art Review: This week's issue explores the diagnosis and new treatments for amyloid cardiomyopathy. ht…
RT @JACCJournals: #JACC State-of-the-Art Review: This week's issue explores the diagnosis and new treatments for amyloid cardiomyopathy. ht…
Nice work! @maz_hanna @MarthaGrogan1 @MathewMaurer
Nice to see another review topic of #amyloid disease ! Increasing the interest is the key to improve awareness! @JACCJournals #HeartFailure @amyloid_papers @AmyloidosisHub
#JACC State-of-the-Art Review: This week's issue explores the diagnosis and new treatments for amyloid cardiomyopathy. https://t.co/crPc72t5eN @ColumbiaMed https://t.co/eLhzGEn60d
RT @JTLLERGO: Transthyretin Amyloid Cardiomyopathy: JACC State-of-the-Art Review @JACCJournals @secardiologia @SACardiologia https://t.co/v…
RT @JTLLERGO: Transthyretin Amyloid Cardiomyopathy: JACC State-of-the-Art Review @JACCJournals @secardiologia @SACardiologia https://t.co/v…
RT @JTLLERGO: Transthyretin Amyloid Cardiomyopathy: JACC State-of-the-Art Review @JACCJournals @secardiologia @SACardiologia https://t.co/v…
RT @JTLLERGO: Transthyretin Amyloid Cardiomyopathy: JACC State-of-the-Art Review @JACCJournals @secardiologia @SACardiologia https://t.co/v…
RT @JTLLERGO: Transthyretin Amyloid Cardiomyopathy: JACC State-of-the-Art Review @JACCJournals @secardiologia @SACardiologia https://t.co/v…
RT @JTLLERGO: Transthyretin Amyloid Cardiomyopathy: JACC State-of-the-Art Review @JACCJournals @secardiologia @SACardiologia https://t.co/v…
RT @JTLLERGO: Transthyretin Amyloid Cardiomyopathy: JACC State-of-the-Art Review @JACCJournals @secardiologia @SACardiologia https://t.co/v…
RT @JTLLERGO: Transthyretin Amyloid Cardiomyopathy: JACC State-of-the-Art Review @JACCJournals @secardiologia @SACardiologia https://t.co/v…
RT @JTLLERGO: Transthyretin Amyloid Cardiomyopathy: JACC State-of-the-Art Review @JACCJournals @secardiologia @SACardiologia https://t.co/v…
RT @JTLLERGO: Transthyretin Amyloid Cardiomyopathy: JACC State-of-the-Art Review @JACCJournals @secardiologia @SACardiologia https://t.co/v…
RT @FormigaFrancesc: Emerging therapies that stabilize TTR have been shown to improve outcomes for patients with ATTR-CM, and TTR silence…
Transthyretin Amyloid Cardiomyopathy: JACC State-of-the-Art Review @JACCJournals @secardiologia @SACardiologia https://t.co/vRapKN7Amr https://t.co/qlPCAbJtt2
RT @FormigaFrancesc: Transthyretin Amyloid Cardiomyopathy: JACC State-of-the-Art Review https://t.co/iawPVHkuP5
RT @FormigaFrancesc: Emerging therapies that stabilize TTR have been shown to improve outcomes for patients with ATTR-CM, and TTR silence…
RT @FormigaFrancesc: Transthyretin Amyloid Cardiomyopathy: JACC State-of-the-Art Review https://t.co/iawPVHkuP5
RT @FormigaFrancesc: Emerging therapies that stabilize TTR have been shown to improve outcomes for patients with ATTR-CM, and TTR silence…
RT @FormigaFrancesc: Transthyretin Amyloid Cardiomyopathy: JACC State-of-the-Art Review https://t.co/iawPVHkuP5
Emerging therapies that stabilize TTR have been shown to improve outcomes for patients with ATTR-CM, and TTR silencer therapies are entering late-phase clinical trials. Early diagnosis will be critical @IcyfaSemi @Dr_Manito @yulnunezvill @chemachir
Transthyretin Amyloid Cardiomyopathy: JACC State-of-the-Art Review https://t.co/iawPVHkuP5